학술논문
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen
Document Type
Article
Author
Source
In: Blood Advances . (Blood Advances, 9 April 2024, 8(7):1612-1620)
Subject
Language
English
ISSN
24739537
24739529
24739529